Finerenone-话题@MedSci - 梅斯（MedSci）

#Finerenone#

11篇内容 | 1208人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2237797, encodeId=17ba223e7971c, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a> <a href='/topic/show?id=55ea121456a5' target=_blank style='color:#2F92EE;'>#射血分数轻微降低或保留的心力衰竭#</a>, objectTitle=JAMA Cardiol：Finerenone在心力衰竭患者中的性别差异疗效与安全性分析（FINEARTS-HF 随机临床试验的二次分析）, objectType=article, longId=851775, objectId=2ed2851e7523, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401009/1728468343109_8538692.png, objectUrl=/article/show_article.do?id=2ed2851e7523, replyNumber=0, likeNumber=19, createdTime=2024-11-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=2ed2851e7523, moduleTitle=JAMA Cardiol：Finerenone在心力衰竭患者中的性别差异疗效与安全性分析（FINEARTS-HF 随机临床试验的二次分析）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2ed2851e7523)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2089223, encodeId=25fa208922336, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>对慢性<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>和<a href='/topic/show?id=e02e1048003f' target=_blank style='color:#2F92EE;'>#糖尿病性肾病#</a>，又是一代新药, objectTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, objectType=article, longId=55622, objectId=6995556228c, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=6995556228c, replyNumber=0, likeNumber=106, createdTime=2022-09-20, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6995556228c, moduleTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6995556228c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968155, encodeId=655d1968155f7, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, objectType=article, longId=219640, objectId=2997219640dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2997219640dc, replyNumber=0, likeNumber=97, createdTime=2021-12-02, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2997219640dc, moduleTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2997219640dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968157, encodeId=a65f196815e48, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=NEJM：Finerenone对肾脏疾病和2型糖尿病患者心血管事件的影响, objectType=article, longId=221770, objectId=bbb7221e708c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbb7221e708c, replyNumber=0, likeNumber=92, createdTime=2021-12-29, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbb7221e708c, moduleTitle=NEJM：Finerenone对肾脏疾病和2型糖尿病患者心血管事件的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bbb7221e708c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968156, encodeId=d4ff19681560f, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险, objectType=article, longId=220478, objectId=821b2204e80a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821b2204e80a, replyNumber=0, likeNumber=95, createdTime=2022-07-30, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821b2204e80a, moduleTitle=Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=821b2204e80a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968158, encodeId=511c1968158bf, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Finerenone用于与2型糖尿病相关的慢性肾病，CHMP持正面意见, objectType=article, longId=292568, objectId=00f32925683d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f32925683d, replyNumber=0, likeNumber=84, createdTime=2022-07-01, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f32925683d, moduleTitle=Finerenone用于与2型糖尿病相关的慢性肾病，CHMP持正面意见, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=00f32925683d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968152, encodeId=5fe1196815278, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Finerenone显著减少患有慢性肾脏病和2型糖尿病成人患者的肾脏和心血管事件, objectType=article, longId=202547, objectId=454c20254e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=454c20254e08, replyNumber=0, likeNumber=80, createdTime=2021-03-20, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=454c20254e08, moduleTitle=Finerenone显著减少患有慢性肾脏病和2型糖尿病成人患者的肾脏和心血管事件, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=454c20254e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968154, encodeId=0783196815490, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Circulation：Finerenone(非奈利酮)可改善慢性肾病合并2型糖尿病患者的心血管结局, objectType=article, longId=207103, objectId=fe7720e103b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe7720e103b5, replyNumber=0, likeNumber=0, createdTime=2021-06-08, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe7720e103b5, moduleTitle=Circulation：Finerenone(非奈利酮)可改善慢性肾病合并2型糖尿病患者的心血管结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe7720e103b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968153, encodeId=03101968153b3, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle= 拜耳Finerenone FIDELIO-DKD III期临床研究结果公布, objectType=article, longId=202599, objectId=ad7320259999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad7320259999, replyNumber=0, likeNumber=109, createdTime=2021-08-02, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad7320259999, moduleTitle= 拜耳Finerenone FIDELIO-DKD III期临床研究结果公布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad7320259999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968151, encodeId=3224196815157, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=Hypertension：非甾体激素受体拮抗剂finerenone防止急性肾损伤介导的慢性肾脏病, objectType=article, longId=92784, objectId=2fc592e84c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc592e84c6, replyNumber=0, likeNumber=0, createdTime=2017-08-24, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc592e84c6, moduleTitle=Hypertension：非甾体激素受体拮抗剂finerenone防止急性肾损伤介导的慢性肾脏病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2fc592e84c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968149, encodeId=171a196814941, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, objectType=article, longId=55622, objectId=6995556228c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6995556228c, replyNumber=0, likeNumber=93, createdTime=2016-06-21, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6995556228c, moduleTitle=第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6995556228c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968150, encodeId=a33b1968150d6, content=<a href='/topic/show?id=e9a9e45455' target=_blank style='color:#2F92EE;'>#Finerenone#</a>, objectTitle=JAMA：Finerenone对糖尿病肾病患者蛋白尿的影响, objectType=article, longId=55808, objectId=adbb55808b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adbb55808b4, replyNumber=0, likeNumber=119, createdTime=2016-07-16, rootId=0, userName=cenghis, userId=afa4194, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adbb55808b4, moduleTitle=JAMA：Finerenone对糖尿病肾病患者蛋白尿的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=adbb55808b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Finerenone

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#Finerenone# #射血分数轻微降低或保留的心力衰竭#

JAMA Cardiol：Finerenone在心力衰竭患者中的性别差异疗效与安全性分析（FINEARTS-HF 随机临床试验的二次分析）

2024-11-19发表于陕西省

小小医者 (审核中...)

前往app查看评论内容

#Finerenone#对慢性#心力衰竭#和#糖尿病性肾病#，又是一代新药

第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段

2022-09-20

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性

2021-12-02

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

NEJM：Finerenone对肾脏疾病和2型糖尿病患者心血管事件的影响

2021-12-29

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险

2022-07-30

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Finerenone用于与2型糖尿病相关的慢性肾病，CHMP持正面意见

2022-07-01

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Finerenone显著减少患有慢性肾脏病和2型糖尿病成人患者的肾脏和心血管事件

2021-03-20

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Circulation：Finerenone(非奈利酮)可改善慢性肾病合并2型糖尿病患者的心血管结局

2021-06-08

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

拜耳Finerenone FIDELIO-DKD III期临床研究结果公布

2021-08-02

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

Hypertension：非甾体激素受体拮抗剂finerenone防止急性肾损伤介导的慢性肾脏病

2017-08-24

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

第三代非甾体MR拮抗剂finerenone对慢性心力衰竭和糖尿病性肾病进入III期临床试验阶段

2016-06-21

cenghis (审核中...)

前往app查看评论内容

#Finerenone#

JAMA：Finerenone对糖尿病肾病患者蛋白尿的影响

2016-07-16

科室
- - 订阅+
  - 更多科室
工具
服务